» Articles » PMID: 12153522

Evidence from Twins for Acquired Cellular Immune Hyperactivity in Type 1 Diabetes

Overview
Journal Immunology
Date 2002 Aug 3
PMID 12153522
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Type 1 diabetes has been associated with an increased frequency of activated T cells and T-cell hyperactivity to non-specific and disease-specific stimuli including the islet autoantigen glutamic acid decarboxylase 65 (GAD). To address whether T-cell hyperactivity is genetic or acquired we measured whole blood cytokines in vitro in response to GAD or tetanus in 18 identical twin pairs, nine discordant for type 1 diabetes. In addition, the activity of 2', 5' oligoadenylate synthetase (OAS) in blood mononuclear cells was measured as a marker of viral infection. Interleukin-2 (IL-2) basally and IL-2 and interferon-gamma (IFN-gamma) in response to GAD, were detected more frequently and at higher levels in diabetic compared to non-diabetic twins. IL-10 was not different between groups. OAS activity was increased in diabetic compared to non-diabetic twins and showed a correlation with basal IL-2 and GAD-stimulated IFN-gamma and IL-10. These findings suggest that T-cell hyperactivity in type 1 diabetes is an acquired trait and could reflect persisting virus expression.

Citing Articles

Environmental determinants of islet autoimmunity (ENDIA): a pregnancy to early life cohort study in children at-risk of type 1 diabetes.

Penno M, Couper J, Craig M, Colman P, Rawlinson W, Cotterill A BMC Pediatr. 2013; 13:124.

PMID: 23941366 PMC: 3751791. DOI: 10.1186/1471-2431-13-124.


T-helper cell tolerance to ubiquitous nuclear antigens.

Nakken B, Davis K, Pan Z, Bachmann M, Farris A Scand J Immunol. 2003; 58(5):478-92.

PMID: 14629620 PMC: 2579760. DOI: 10.1046/j.1365-3083.2003.01323.x.

References
1.
Peakman M, Leslie R, Alviggi L, Hawa M, Vergani D . Persistent activation of CD8+ T-cells characterizes prediabetic twins. Diabetes Care. 1996; 19(11):1177-84. DOI: 10.2337/diacare.19.11.1177. View

2.
Bonnevie-Nielsen V, Martensen P, Justesen J, Kyvik K, Kristensen B, Levin K . The antiviral 2',5'-oligoadenylate synthetase is persistently activated in type 1 diabetes. Clin Immunol. 2000; 96(1):11-8. DOI: 10.1006/clim.2000.4874. View

3.
Atkinson M, Bowman M, Campbell L, Darrow B, Kaufman D, Maclaren N . Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest. 1994; 94(5):2125-9. PMC: 294659. DOI: 10.1172/JCI117567. View

4.
Tun R, Peakman M, Alviggi L, Hussain M, Lo S, Shattock M . Importance of persistent cellular and humoral immune changes before diabetes develops: prospective study of identical twins. BMJ. 1994; 308(6936):1063-8. PMC: 2539935. DOI: 10.1136/bmj.308.6936.1063. View

5.
Kumar D, Gemayel N, Deapen D, Kapadia D, Yamashita P, Lee M . North-American twins with IDDM. Genetic, etiological, and clinical significance of disease concordance according to age, zygosity, and the interval after diagnosis in first twin. Diabetes. 1993; 42(9):1351-63. DOI: 10.2337/diab.42.9.1351. View